Chemoreduction for Retinoblastoma May Prevent Intracranial Neuroblastic Malignancy (Trilateral Retinoblastoma)
- 1 September 2001
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 119 (9) , 1269-1272
- https://doi.org/10.1001/archopht.119.9.1269
Abstract
Research from JAMA Ophthalmology — Chemoreduction for Retinoblastoma May Prevent Intracranial Neuroblastic Malignancy (Trilateral Retinoblastoma)Keywords
This publication has 8 references indexed in Scilit:
- Chemoreduction and Local Ophthalmic Therapy for Intraocular RetinoblastomaJournal of Clinical Oncology, 2000
- Trilateral Retinoblastoma: A Meta-Analysis of Hereditary Retinoblastoma Associated With Primary Ectopic Intracranial RetinoblastomaJournal of Clinical Oncology, 1999
- Combined Chemoreduction and Adjuvant Treatment for Intraocular RetinoblastomaOphthalmology, 1997
- Chemoreduction in the Initial Management of Intraocular RetinoblastomaArchives of Ophthalmology (1950), 1996
- Trilateral retinoblastoma-incidence and outcome: A decade of experienceInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Successful Therapy for Trilateral RetinoblastomaAmerican Journal of Ophthalmology, 1992
- Retinoblastoma and intracranial malignancyCancer, 1977
- Biostatistical Analysis.Journal of the American Statistical Association, 1975